27582 Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)

Gil Yosipovitch; Mette Deleuran; John Su; Luz Fonacier; Andrew G Bushmakin; Joseph C Cappelleri; Claire Feeney; Andrew Thorpe; Ricardo Rojo; Hernan Valdez; Daniela E Myers

doi:10.1016/j.jaad.2021.06.624

Journal article

27582 Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)

Gil Yosipovitch, Mette Deleuran, John Su, Luz Fonacier, Andrew G Bushmakin, Joseph C Cappelleri, Claire Feeney, Andrew Thorpe, Ricardo Rojo, Hernan Valdez, …

Journal of the American Academy of Dermatology, Vol.85(3), pp.AB153-AB153

2021-09

DOI: https://doi.org/10.1016/j.jaad.2021.06.624

Metrics

4 Record Views

Details

Title: 27582 Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)
Creators: Gil Yosipovitch - University of Miami
Mette Deleuran - Aarhus University Hospital
John Su - University of Melbourne
Luz Fonacier - NYU Winthrop Hospital
Andrew G Bushmakin - Pfizer
Joseph C Cappelleri - Pfizer
Claire Feeney - Pfizer
Andrew Thorpe - Pfizer
Ricardo Rojo - Pfizer
Hernan Valdez - Pfizer
Daniela E Myers - Pfizer
Publication Details: Journal of the American Academy of Dermatology, Vol.85(3), pp.AB153-AB153
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031714403402976